IMAP INJ 2MG/ML DIN 00368393
Status: Cancelled Post Market
Holder: MCNEIL PHARMACEUTICAL, DIVISION OF ORTHO-MCNEIL INC.
Molecule: FLUSPIRILENE
Health Canada record
| Active ingredient(s) | FLUSPIRILENE 2 MG |
|---|---|
| Dosage form | Suspension |
| Route | Intramuscular |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N05AG01 FLUSPIRILENE |
| Original market date | 31-Dec-1977 |
| Current status date | 12-Mar-1998 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FLUSPIRILENE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00542903 | IMAP FORTE INJ 10MG/ML | MCNEIL PHARMACEUTICAL, DIVISION OF ORTHO-MCNEIL INC. | Suspension | FLUSPIRILENE 10 MG | Cancelled Post Market |
International API supply for FLUSPIRILENE
1 valid EDQM Certificates of Suitability from 1 holders.
Request a quote for IMAP INJ 2MG/ML